IONS vs STKL · rev $514.0M vs P/E 50, rev $723.7M
Ionis Pharmaceuticals Inc (IONS) versus SunOpta Inc. (STKL) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
SunOpta Inc. (STKL) is a beverages - non-alcoholic company listed on NASDAQ.
Latest reported IONS revenue for 2026-06-30 was $514.0M. Net income was -$207.2M. IONS currently screens at market cap $12.28B.
Latest reported STKL revenue for 2024-12-28 was $723.7M. Net income was -$17.4M. STKL currently screens at market cap $771.0M and trailing P/E 50.0.
IONS currently screens at market cap $12.28B. STKL currently screens at market cap $771.0M and trailing P/E 50.0.
Not investment advice. Open the IONS and STKL stock pages for the full models.
Not investment advice.